Myocarditis and Pericarditis in A young boy After BNT162b2 Vaccine in Saraburi, Thailand

Authors

  • Ravipol Jurjai Emergency department, Saraburi Hospital
  • Kanokvalee Santimahakullert Pediatric department, Saraburi Hospital

Keywords:

pediatric, vaccine, myopericarditis, covid-19, myocarditis, pericarditis

Abstract

The predominant adverse events of the mRNA vaccine are myocarditis and pericarditis. These conditions are diagnosed by serum troponin level, electrocardiogram (ECG), and echocardiogram. A young male is one of the significant risk factors being reported so far. Chest pain is a symptom that occurs in all pediatric patients with myocarditis or pericarditis. In this report, we documented a typical case of a young male patient who received his first dose of the BNT162b2 vaccine and developed chest pain. His ECG and serum troponin level showed abnormalities which were associated with myopericarditis. Finally, he was treated with non-steroidal anti-inflammatory drugs (NSAIDs) and his symptoms were fully recovered.

References

Pfizer Inc. BioNTech And Pfizer Announce Regulatory Approval From German Authority Paul-Ehrlich-Institut To Commence First Clinical Trial Of COVID-19 Vaccine Candidates [Internet]. 2020 Apr 22 [cited Nov 21, 2021]. Available from: https://www.pfizer.com/news/press-release/press-release-detail/biontech_and_pfizer_announce_regulatory_approval_from_german_authority_paul_ehrlich_institut_to_commence_first_clinical_trial_of_covid_19_vaccine_candidates

Food and Drug Administration. Comirnaty and Pfizer-BioNTech COVID-19 Vaccine [Internet]. 2021 Oct 29 [cited Nov 21, 2021]. Available from: https://www.fda.gov/emergencypreparedness-and-response/coronavirusdisease-2019-covid-19/comirnaty-and-pfizer-biontech-covid-19-vaccine#comirnaty

European Medicines Agency. European Medicines Agency. Comirnaty and Spikevax: possible link to very rare cases of myocarditis and pericarditis [Internet]. 2021 Jul 9 [cited Nov 21, 2021]. Available from: https://www.ema.europa.eu/en/news/comirnaty-spikevax-possible-link-veryrare-cases-myocarditis-pericarditis.

Høeg TB, Krug A, Stevenson J, Mandrola J. SARS-CoV-2 mRNA Vaccination-Associated Myocarditis in Children Ages 12-17: A Stratified National Database Analysis [Internet]. Epidemiology; 2021 Sep [cited 2021 Nov 17]. Available from: http://medrxiv.org/lookup/doi/10.1101/2021.08.30.21262866

BBC news. [Pediatric COVID-19 vaccine: Thai government revealed vaccination program in students aged 12 through 18 years approximately five million in October 2021] [Internet]. 2021 Sep 29 [cited Nov 21,2021]. Available from: https://www.bbc.com/thai/thailand-58535260

Eslick GD. Epidemiology and Risk Factors of Pediatric Chest Pain: A Systematic Review. Pediatric Clinics of North America. 2010 Dec;57(6):1211–9.

Elamm C, Fairweather D, Cooper LT. Republished: Pathogenesis and diagnosis of myocarditis. Postgrad Med J. 2012 Sep;88(1043):539–44.

Law YM, Lal AK, Chen S, Čiháková D, Cooper LT, Deshpande S, et al. Diagnosis and Management of Myocarditis in Children: A Scientific Statement From the American Heart Association. Circulation [Internet]. 2021 Aug 10 [cited 2022 Feb 20];144(6). Available from: https://www.ahajournals.org/doi/10.1161/CIR.0000000000001001

Butts RJ, Boyle GJ, Deshpande SR, Gambetta K, Knecht KR, Prada-Ruiz CA, et al. Characteristics of Clinically Diagnosed Pediatric Myocarditis in a Contemporary Multi-Center Cohort. Pediatr Cardiol. 2017 Aug;38(6):1175–82.

Tunuguntla H, Jeewa A, Denfield SW. Acute Myocarditis and Pericarditis in Children. Pediatrics in Review. 2019 Jan;40(1):14–25.

Kindermann I, Barth C, Mahfoud F, Ukena C, Lenski M, Yilmaz A, et al. Update on Myocarditis. Journal of the American College of Cardiology. 2012 Feb;59(9):779–92.

Skouri HN, Dec GW, Friedrich MG, Cooper LT. Noninvasive Imaging in Myocarditis. Journal of the American College of Cardiology. 2006 Nov;48(10):2085–93.

Putschoegl A, Auerbach S. Diagnosis, Evaluation, and Treatment of Myocarditis in Children. Pediatric Clinics of North America. 2020 Oct;67(5):855–74.

Gargano JW, Wallace M, Hadler SC, Langley G, Su JR, Oster ME, et al. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices-United States, June 2021. MMWR Morb Mortal Wkly Rep. 2021 Jul 9;70(27):977–82.

Dionne A, Sperotto F, Chamberlain S, Baker AL, Powell AJ, Prakash A, et al. Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children. JAMA Cardiol. 2021 Dec 1;6(12):1446.

Downloads

Published

2023-12-14

How to Cite

1.
Jurjai R, Santimahakullert K. Myocarditis and Pericarditis in A young boy After BNT162b2 Vaccine in Saraburi, Thailand. TJEM [Internet]. 2023 Dec. 14 [cited 2024 May 9];4(2):48-56. Available from: https://he02.tci-thaijo.org/index.php/TJEM/article/view/259826